| Angelika Alexandra Foley, APN | |
|
1357 W 103rd St, Chicago, IL 60643-2392 | |
| (773) 238-0800 | |
| (773) 881-7234 |
| Full Name | Angelika Alexandra Foley |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 8 Years |
| Location | 1357 W 103rd St, Chicago, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003350695 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Advocate Trinity Hospital | Chicago, IL | Hospital |
| Advocate Christ Hospital & Medical Center | Oak lawn, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advocate Health And Hospitals Corporation | 7810800935 | 2422 |
News Archive
In addition to remembering to take the medication prescribed by their cardiologists at the right times and going to the trouble of making healthy lifestyle changes, patients with high blood pressure (hypertension) can include a pleasing beneficial activity in routine treatment of the disease thanks to the discovery that listening to music significantly enhances the effect of anti-hypertensive drugs.
A small compound called an aptamer that specifically targets and stimulates a human immune cell can greatly increase the effectiveness of an immunotherapeutic drug designed to destroy malignant or virus-infected cells. The development of a novel apatamer that recognizes activated T-lymphocytes and can boost the therapeutic effect of cell-based vaccines is described in an article in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.
By combining a conventional laboratory measurement of blood clotting time (known as the International Normalized Ratio or INR) with a new test of blood clot strength, based upon thrombelastography (TEG), researchers at the University of Colorado's Department of Surgery, Denver, are able to quickly and efficiently assess the overall ability of blood to clot and identify trauma patients who were most in need of a massive blood transfusion.
VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new Cat B 750 FAST(TM) imaging agent for measuring and monitoring cathepsin B activity associated with disease progression and therapeutic response in vivo. Cathepsin B expression is well known as a key biomarker and therapeutic target in a range of diseases, including atherosclerosis, oncology, and arthritis.
› Verified 2 days ago
| Entity Name | Advocate Health And Hospitals Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700824455 PECOS PAC ID: 7810800935 Enrollment ID: O20031106000064 |
News Archive
In addition to remembering to take the medication prescribed by their cardiologists at the right times and going to the trouble of making healthy lifestyle changes, patients with high blood pressure (hypertension) can include a pleasing beneficial activity in routine treatment of the disease thanks to the discovery that listening to music significantly enhances the effect of anti-hypertensive drugs.
A small compound called an aptamer that specifically targets and stimulates a human immune cell can greatly increase the effectiveness of an immunotherapeutic drug designed to destroy malignant or virus-infected cells. The development of a novel apatamer that recognizes activated T-lymphocytes and can boost the therapeutic effect of cell-based vaccines is described in an article in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.
By combining a conventional laboratory measurement of blood clotting time (known as the International Normalized Ratio or INR) with a new test of blood clot strength, based upon thrombelastography (TEG), researchers at the University of Colorado's Department of Surgery, Denver, are able to quickly and efficiently assess the overall ability of blood to clot and identify trauma patients who were most in need of a massive blood transfusion.
VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new Cat B 750 FAST(TM) imaging agent for measuring and monitoring cathepsin B activity associated with disease progression and therapeutic response in vivo. Cathepsin B expression is well known as a key biomarker and therapeutic target in a range of diseases, including atherosclerosis, oncology, and arthritis.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Angelika Alexandra Foley, APN 29373 Network Pl, Chicago, IL 60673-1293 Ph: (847) 390-5900 | Angelika Alexandra Foley, APN 1357 W 103rd St, Chicago, IL 60643-2392 Ph: (773) 238-0800 |
News Archive
In addition to remembering to take the medication prescribed by their cardiologists at the right times and going to the trouble of making healthy lifestyle changes, patients with high blood pressure (hypertension) can include a pleasing beneficial activity in routine treatment of the disease thanks to the discovery that listening to music significantly enhances the effect of anti-hypertensive drugs.
A small compound called an aptamer that specifically targets and stimulates a human immune cell can greatly increase the effectiveness of an immunotherapeutic drug designed to destroy malignant or virus-infected cells. The development of a novel apatamer that recognizes activated T-lymphocytes and can boost the therapeutic effect of cell-based vaccines is described in an article in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.
By combining a conventional laboratory measurement of blood clotting time (known as the International Normalized Ratio or INR) with a new test of blood clot strength, based upon thrombelastography (TEG), researchers at the University of Colorado's Department of Surgery, Denver, are able to quickly and efficiently assess the overall ability of blood to clot and identify trauma patients who were most in need of a massive blood transfusion.
VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new Cat B 750 FAST(TM) imaging agent for measuring and monitoring cathepsin B activity associated with disease progression and therapeutic response in vivo. Cathepsin B expression is well known as a key biomarker and therapeutic target in a range of diseases, including atherosclerosis, oncology, and arthritis.
› Verified 2 days ago
Mr. Gerald M. Bedore, APN/CNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 835 S Wolcott Ave Rm E-144, Chicago, IL 60612 Phone: 312-996-7420 Fax: 312-413-8485 | |
Stacy Ervin, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 401 N Michigan Ave, Chicago, IL 60611 Phone: 866-825-3227 | |
Angela Obondo Peterson, APRN, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 259 E Erie St Fl 17, Chicago, IL 60611 Phone: 312-926-6000 Fax: 312-926-0516 | |
Katherine Cappitelli, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 676 N Saint Clair St Ste 2125, Chicago, IL 60611 Phone: 312-472-4218 | |
Catherine L Chung, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2142 S Archer Ave, Chicago, IL 60616 Phone: 312-326-1408 | |
Tricia Muir, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 850 W Irving Park Rd, Chicago, IL 60613 Phone: 773-525-6780 |